J. L. Burgos,* J. G. Kahn,† S. A. Strathdee,* A. Valencia-Mendoza,‡ S. Bautista-Arredondo,‡ R. Laniado-Laborin,§ R. Castañeda,§ R. Deiss,* R. S. Garfein*


* Division of Global Public Health, School of Medicine, University of California San Diego, San Diego, California, † Philip R. Lee Institute for Health Policy Studies and Department of Epidemiology & Biostatistics, University of California San Francisco, San Francisco, California, USA; ‡ Dirección de Economía de la Salud, Instituto Nacional de Salud Pública, Cuernavaca, § Facultad de Medicina, Universidad Autónoma de Baja California, Tijuana, México.

Attachments:
Download this file (530_PUB_ART_Burgos_IJTLD_2009.pdf)530_PUB_ART_Burgos_IJTLD_2009.pdf[ ]122 kB

Laith J. Abu-Raddada,1, Lorenzo Sabatellia, Jerusha T. Achterberga,b,c, Jonathan D. Sugimotoa,b, Ira M. Longini, Jr.a,d, Christopher Dyee, and M. Elizabeth Hallorana,d,2

aVaccine and Infectious Disease Institute, Fred Hutchinson Cancer Research Center, Seattle, WA 98109; Departments of bEpidemiology, cAnthropology, and dBiostatistics, University of Washington, Seattle, WA 98195; and eOffice of HIV/AIDS, Tuberculosis, Malaria, and Neglected Tropical Diseases, World Health Organization, CH-1211 Geneva 27, Switzerland Edited by Simon A. Levin, Princeton Universtiy, Princeton, NJ, and approved June 4, 2009 (received for review February 18, 2009)

Madhukar Pai, M.D., Ph.D.1 and Richard O’Brien, M.D.2


ABSTRACT
Tuberculosis (TB) continues to be the world’s most important infectious cause of morbidity and mortality among adults. Nearly 9 million people develop TB disease each year, and an estimated 1.6 million die from the disease. Despite this enormous global burden, case detection rates are low, posing serious hurdles for TB control. Conventional TB diagnosis continues to rely on antiquated tests such as sputum smear microscopy, culture, tuberculin skin test, and chest radiography. These tests have several limitations and perform poorly in populations affected by the HIV epidemic. Conventional tests for detection of drug resistance are time consuming, tedious, and inaccessible in most settings.

Attachments:
Download this file ('Brien_SRCCM_2008.pdf)'Brien_SRCCM_2008.pdf[ ]640 kB

P. Daley,* J. S. Michael,† P. Hmar,† A. Latha,* P. Chordia,* D. Mathai,* K. R. John,‡ M. Pai§ 
* Department of Medicine, † Department of Microbiology, and ‡ Department of Community Health, Christian Medical College, Vellore, India; § Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Canada

Peter Daley1, Joy Sarojini Michael2, Kalaiselvan S1, Asha Latha1, Dilip Mathai1, K. R. John3, Madhukar Pai4*
1 Department of Medicine, Christian Medical College Vellore, Vellore, India, 2 Department of Microbiology, Christian Medical College Vellore, Vellore, India, 3 Department of Community Health, Christian Medical College Vellore, Vellore, India, 4 Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada

Attachments:
Download this file (505_PUB_art_Daley_PLoSOne_2009.pdf)505_PUB_art_Daley_PLoSOne_2009.pdf[ ]167 kB

Keertan Dhedaa,b,c, Richard van Zyl Smita, Motasim Badria and Madhukar Paid

aDivision of Pulmonology, Department of Medicine, University of Cape Town Lung Institute, University of Cape Town, Cape Town, South Africa, bCentre for Infectious Diseases and International Health, University College London Medical School, London, UK, cInstitute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa and dDepartment of Epidemiology & Biostatistics, McGill University, Montreal, Canada Correspondence to Keertan Dheda, MBBCh, FCP(SA), FCCP, PhD (Lond), Associate Professor of Respiratory Medicine, Lung Infection and Immunity Unit, Division of Pulmonology & Clinical Immunology, Department of Medicine, University of Cape Town, J flr. Old Main Bldg., Groote Schuur Hospital Observatory, 7925 Cape Town, South Africa
Tel: +27 21 4066509; fax: +27 21 4486815;
e-mail: Este endereço de email está sendo protegido de spambots. Você precisa do JavaScript ativado para vê-lo. or Este endereço de email está sendo protegido de spambots. Você precisa do JavaScript ativado para vê-lo. 
Current Opinion in Pulmonary Medicine 2009,
15:188–200

Sobre a REDE-TB

A Rede Brasileira de Pesquisa em Tuberculose (REDE-TB) é uma Organização Não Governamental (ONG) de direito privado sem fins lucrativos, preocupada em auxiliar no desenvolvimento não só de novos medicamentos, novas vacinas, novos testes diagnósticos e novas estratégias de controle de TB, mas também na validação dessas inovações tecnológicas, antes de sua comercialização no país e/ou de sua implementação nos Programa de Controle de TB no País.


bt2

Contato

E-mail: redetb.rp@gmail.com

Tel: +55 (21)3938 - 2426
Tel/ Fax: +55 (21)3938 - 2431.

Endereço: Avenida Carlos Chagas Filho, 791, Cidade Universitária - Ilha do Fundão, Rio de Janeiro, RJ - Brasil. CEP: 21941-904

Assine a newsletter da REDE-TB

Curta REDE-TB no Facebook